Philippe Pinton | Senior Vice President, Head Global Research & Medical
Ferring Pharmaceuticals

Dr. Philippe Pinton is Senior Vice-President, Head of Global Research and Medical (GRM) at Ferring Pharmaceuticals. The GRM structure is an integrated matrix that brings Ferring Pharmaceuticals Research and Medical expertise together ‘end-to-end’, from Discovery and Research to late-stage Clinical Development and Medical Affairs, in an effective and united set-up to drive patient value, delivering and sustaining a portfolio of innovative medicines. Dr. Philippe Pinton has over 25 years’ experience in the Pharmaceutical Industry across Research & Development and Medical Affairs, in Asia, Europe and the USA, in major pharmaceutical companies, as Eli Lilly & Company, Novartis and Takeda. He has also developed his own entrepreneurial skills by founding and leading Japan based companies dedicated to healthcare consultancy and to arts. He received his MD., MSc., and PhD., degrees from the Universities of Lille and of Paris, and his executive MBA from the HEC business school (France). Prior to joining the Pharmaceutical Industry, he has been a resuscitation ward hospital practitioner. He has authored over 175 manuscripts or abstracts in peer-to-peer medical journals or scientific congresses. He is a board member of healthcare start-up, academic society and scientific journal. He is currently based in Denmark and his most recent works have notably explored the benefit of peptides, microbiota transplants, gene therapies or biologic agents in auto-immune or inflammatory gastroenterology diseases, reproductive medicine and infertility, as well as in urology and uro-oncology, articulating standard research and artificial intelligence, developing computational models integrating multiple omics and performing in silico clinical trials to accelerate first in human dose and later regulatory programs while better understanding patients’ treatment response and related comorbidome.